Error loading player: No playable sources found

Player size: small large

Therapeutics I: Ex Vivo Editing

Date

March 9, 2021

Co-Chairs

Rachel E. Haurwitz, PhD

Caribou Biosciences, Inc.

Nicole Gaudelli, PhD

Beam Therapeutics

Tracks

Therapeutics I: Ex Vivo Editing

Related Products

Thumbnail for The Future is Allogeneic - Translating a CRISPR Platform into Gene-Edited Cell Therapies

The Future is Allogeneic - Translating a CRISPR Platform into Gene-Edited Cell Therapies

Thumbnail for The Genome Editing Revolution - Translating Genome Editing Technologies into Human Therapies

The Genome Editing Revolution - Translating Genome Editing Technologies into Human Therapies

THE GENOME EDITING REVOLUTION: TRANSLATING GENOME EDITING TECHNOLOGIES INTO HUMAN THERAPIES

Thumbnail for [NOT AVAILABLE ON DEMAND] Short Talk: Knockout of NKG2A by CRISPR in Human NK Cells Enhance their Cytotoxic Activity Against Solid Tumors

[NOT AVAILABLE ON DEMAND] Short Talk: Knockout of NKG2A by CRISPR in Human NK Cells Enhance their Cytotoxic Activity Against Solid Tumors

Thumbnail for An Adenine Base Editing Strategy for the Treatment of Sickle Cell Disease by Elimination of the Pathogenic Globin Protein

An Adenine Base Editing Strategy for the Treatment of Sickle Cell Disease by Elimination of the Pathogenic Globin Protein

Privacy Policy Update: We value your privacy and want you to understand how your information is being used. To make sure you have current and accurate information about this sites privacy practices please visit the privacy center by clicking here.